I
Insitro
Machine Learning for Drug Discovery
South San Francisco, CA
400+
About Insitro
Industry:
TechBio
Founded:
2018
Founders:
Daphne Koller
Status:
Private
Funding & Growth
Total Raised:
$700M+
Valuation:
$2.4B
Stage:
Series C
Key Investors:
a16z
GV
Foresite Capital
ARCH Venture
✓ Pros
- • World-class ML talent
- • Daphne Koller leadership
- • Strong funding
- • Cutting-edge science
- • South SF location
✗ Cons
- • High bar for hiring
- • Still early stage
- • Competitive environment
- • Startup uncertainty